Generic Injectables Market is Projected to Showcase Significant Growth up to 2025

The global generic Injectables market was estimated an 11.6% compound annual growth rate (CAGR) of during the forecast period 2019–2025.

Some of the key players in the market are Pfizer, Novartis AG, Sanofi SA, Cipla, Samsung Biologics, AstraZeneca plc, Mylan NV, Dr. Reddys Laboratories, Merck & Co. Inc. and Others

Rising patent drug expiry to boost the global generic injectables Market

The increasing patents of branded drugs are expected to expire in the near future, and this is driving the market growth of generic injectables. Some of the major patent expirations in 2017 are Alimta, Norditropin, Eloxatin, and Remodulin. These patent expirations will demand effective generic injectables to overcome drug shortage and issues like patent expiry, further fueling market growth.

The global generic injectables market is bifurcated on the basis of Drug Delivery System Type: Orals, Injectables, Dermal/Topical, Inhalers. Based on Therapeutic Areas: Oncology, Anaesthesia, Anti-Infectives, Parenteral Nutrition, Cardiovascular Diseases. On the basis of Containers: Vials, Ampoules, Premix, Prefilled Syringes and Based on Distribution Channel: Hospital Pharmacy and Retail Pharmacy

Request a Sample Report to gain comprehensive insights with COVID -19 Impact at @

The Asia Pacific Region Expected to Witness fastest Growth in the Global Generic Injectables Market

 Based on geographical analysis, the global generic injectables market is divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The growth of the generic injectables market across Asia Pacific is due to the presence of a higher pool of patients suffering from various diseases that require generic drugs, patent expiration of many drugs in the future, shortage of drugs. Furthermore, the surge in healthcare expenditure and new technological advancements will propel the growth of the industry in the region. In addition to this, government initiatives focused on the treatment and R&D spends in this region will boost the growth of the market.

Explore Full Report With Detail Analysis With COVID -19 Impact @

 The global generic injectables market is segmented as follows:

 By Drug Delivery System Type:





By Therapeutic Areas:




-Parenteral Nutrition

-Cardiovascular Diseases

By Containers:




-Prefilled Syringes

By Distribution Channel:

-Hospital Pharmacy

-Retail Pharmacy

By region:

North America

-The U.S.




-The UK




-Rest of Europe

Asia Pacific




-South Korea

-Southeast Asia

-Rest of Asia Pacific

Latin America



-Rest of Latin America

Middle East & Africa


-South Africa

-Rest of Middle East & Africa

Do You Have Any Query Or Report Customization? Ask to Our Expert @

About Us:

Fast. MR offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant, and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.

Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

Contact US:

If you have any queries about this report or would like further information, please contact us our team is ready to assist your queries.

Support 24/7 :- +1 518-300-1215

Email at :-  [email protected]

Follow Us – Facebook , Linkedin , Twitter

More Industry Update-

Leave a Reply

Your email address will not be published. Required fields are marked *